WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of TrueSite TIâ„¢, an industry-leading targeted integration ...
WuXi Biologics, a global CRDMO, has launched TrueSite TI, a targeted integration (TI)-based CHO cell line platform.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback